Endocannabinoid levels differed in RA and tracked disease activity in women
Significant changes in circulating endocannabinoids correlate with disease severity in rheumatoid arthritis: a cross-sectional study.
AI Summary
This single-center, cross-sectional study asked whether circulating endocannabinoids and related molecules differ in rheumatoid arthritis (RA) and track disease activity. Researchers measured plasma levels of 25 molecules in 43 women with RA and 38 healthy female controls; the analysis adjusted for age and cannabis use. Several molecules, including palmitoylethanolamide (PEA), were higher in the RA group, while anandamide (AEA) and two other measured molecules were lower.
š” Key Findings
š
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
In septic rats, lenabasum reduced lung injury markers over 24 hours
Canine tumours show varied CB1 and CB2 expression; treatment effects remainā¦
Lab tests confirmed metabolites, some of which activated CB1
Explore More Research
Stay informed about the latest cannabis science.